Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/483,052external-prioritypatent/US4766075A/en
Priority to SI8310997ApriorityCriticalpatent/SI8310997B/sl
Application filed by Genentech Inc.filedCriticalGenentech Inc.
Publication of YU99783ApublicationCriticalpatent/YU99783A/sh
Publication of YU47397BpublicationCriticalpatent/YU47397B/sh
Priority to HRP-997/83Aprioritypatent/HRP950158B1/xx
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
POSTUPAK ZA DOBIVANJE AKTIVATORA PLAZMINOGENA LJUDSKOG TKIVA, naznačen time, što obuhvata dobivanje cDNA iz mRNA ekstrahovane iz melanoma ćelije govečeta i izolovanje DNA sekvence koja ima restrikcionu osnovnu strukturnu formulu prikazanu na sl. 4 za predpostavljenu aktivatorsku sekvencu zrelog tkivanog plazminogena i koja kodira 527 amino kiselinski polipeptid koji ima aktivatorsku funkciju humanog tkivnog plazminogena. Prijava sadrži još 2 nezavisna i 8 zavisnih zahteva.
YU99783A1982-05-051983-05-06Postupak za dobivanje aktivatora plazminogena ljudskog tkiva
YU47397B
(sh)
Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa.